Recent trends in treatment and management of filariasis.
暂无分享,去创建一个
[1] A. Hoerauf. Filariasis: new drugs and new opportunities for lymphatic filariasis and onchocerciasis , 2008, Current opinion in infectious diseases.
[2] Fengfei Wang,et al. Confirmation of elimination of lymphatic filariasis by an IgG4 enzyme-linked immunosorbent assay with urine samples in Yongjia, Zhejiang Province and Gaoan, Jiangxi Province, People's Republic of China. , 2007, The American journal of tropical medicine and hygiene.
[3] J. Critchley,et al. Diethylcarbamazine (DEC)-medicated salt for community-based control of lymphatic filariasis. , 2007, The Cochrane database of systematic reviews.
[4] J. Kazura,et al. Mass chemotherapy options to control lymphatic filariasis: a systematic review. , 2005, The Lancet. Infectious diseases.
[5] P. Vanamail,et al. Comparison of an immunochromatographic card test with night blood smear examination for detection of Wuchereria bancrofti microfilaria carriers. , 2004, The National medical journal of India.
[6] Achim Hoerauf,et al. Reliable and frequent detection of adult Wuchereria bancrofti in Ghanaian women by ultrasonography , 2004, Tropical medicine & international health : TM & IH.
[7] E. Pearlman,et al. The role of endosymbiotic Wolbachia bacteria in filarial disease , 2004, Cellular microbiology.
[8] M. Itoh,et al. Sensitive and specific enzyme-linked immunosorbent assay for the diagnosis of Wuchereria bancrofti infection in urine samples. , 2001, The American journal of tropical medicine and hygiene.
[9] Mark J. Taylor,et al. Inflammatory Responses Induced by the Filarial Nematode Brugia malayi Are Mediated by Lipopolysaccharide-like Activity from Endosymbiotic Wolbachia Bacteria , 2000, The Journal of experimental medicine.
[10] D. Addiss,et al. Evaluation of the whole blood filariasis ICT test for short-term monitoring after antifilarial treatment. , 2000, The American journal of tropical medicine and hygiene.
[11] F. Abath,et al. Diagnosis of Wuchereria bancrofti infection by the polymerase chain reaction using urine and day blood samples from amicrofilaraemic patients. , 1998, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[12] A. Hightower,et al. Randomised placebo-controlled comparison of ivermectin and albendazole alone and in combination for Wuchereria bancrofti microfilaraemia in Haitian children , 1997, The Lancet.
[13] J. Habbema,et al. Ivermectin for the chemotherapy of bancroftian filariasis: a meta‐analysis of the effect of single treatment , 1997, Tropical medicine & international health : TM & IH.
[14] S. Williams,et al. A polymerase chain reaction-based assay for detection of Wuchereria bancrofti in human blood and Culex pipiens. , 1997, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[15] L. Nicolas,et al. Reduction of Wuchereria bancrofti adult worm circulating antigen after annual treatments of diethylcarbamazine combined with ivermectin in French Polynesia. , 1997, The Journal of infectious diseases.
[16] J. D. Smyth,et al. The mechanisms of action of antiprotozoal and anthelmintic drugs in man. , 1997, General pharmacology.
[17] D. Addiss,et al. Assessment of the efficacy of diethylcarbamazine on adult Wuchereria bancrofti in vivo. , 1997, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[18] D. Addiss,et al. Evaluation of the Og4C3 ELISA in Wuchereria bancrofti infection: infected persons with undetectable or ultra‐low microfilarial densities , 1996, Tropical medicine & international health : TM & IH.
[19] D. Meyrowitsch,et al. Mass diethylcarbamazine chemotherapy for control of bancroftian filariasis through community participation: comparative efficacy of a low monthly dose and medicated salt. , 1996, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[20] J. McCarthy,et al. Clearance of circulating filarial antigen as a measure of the macrofilaricidal activity of diethylcarbamazine in Wuchereria bancrofti infection. , 1995, The Journal of infectious diseases.
[21] G Dreyer,et al. Direct assessment of the adulticidal efficacy of a single dose of ivermectin in bancroftian filariasis. , 1995, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[22] J. Chodakewitz. Ivermectin and lymphatic filariasis: a clinical update , 1995 .
[23] D. Freedman,et al. Lymphoscintigraphic analysis of lymphatic abnormalities in symptomatic and asymptomatic human filariasis. , 1994, The Journal of infectious diseases.
[24] W. Campbell,et al. Ivermectin in human medicine. , 1994, The Journal of antimicrobial chemotherapy.
[25] T. Nutman,et al. Effectiveness of diethylcarbamazine in treating loiasis acquired by expatriate visitors to endemic regions: long-term follow-up. , 1994, The Journal of infectious diseases.
[26] R. Maizels,et al. Immunological modulation and evasion by helminth parasites in human populations , 1993, Nature.
[27] R. Speare,et al. A comparison of the Og4C3 antigen capture ELISA, the Knott test, an IgG4 assay and clinical signs, in the diagnosis of Bancroftian filariasis. , 1993, Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit.
[28] G. Weil,et al. Changes in circulating parasite antigen levels after treatment of bancroftian filariasis with diethylcarbamazine and ivermectin. , 1991, The Journal of infectious diseases.
[29] A. Sadanandam,et al. A controlled trial of ivermectin and diethylcarbamazine in lymphatic filariasis. , 1990, The New England journal of medicine.